4 Hrs
Source:
الشرق
Drug vision-loss warning
The US Food and Drug Administration has required manufacturers of GLP-1 drugs, including Ozempic, Mounjaro and Wegovy, to add a warning about a possible increased risk of a rare condition that can cause sudden vision loss. A review of 126 trials involving more than 134,000 people identified 10 possible cases among users of these drugs, compared with five in the comparison groups. The incidence was 6.4 versus 3.8 cases per 100,000 people per year, though no definitive causal link was established. The agency urged patients to seek medical advice immediately if they experience vision loss, blurred vision or blind spots, and said suspected cases should be referred to eye specialists.
Size: 120%Text Size
Notice: This Is an AI-Generated Summary
Comments (0)